TCMD
Tactile Systems Technology, Inc.$26.27-0.55 (-2.03%)Prev Close$26.81·MCap$600.6M·P/E30.49·Vol73.9K·Yield—
▲
Buys (12M)
0
$0.00
▼
Sells (12M)
11
$2.27M
◆
Net Activity
Net Seller
$2.27M
●
Active Insiders
5
last 12 mo
Over the past 12 months, insider activity at Tactile Systems Technology, Inc. (TCMD) has been exclusively selling, with 0 insider purchases totaling $0.00 and 11 insider sales totaling $2.27M. The most recent insider transaction was by BURKE WILLIAM W (director), who sold $135.0K worth of shares on Nov 9, 2026. Tactile Systems Technology, Inc. operates in the Healthcare sector, within the Medical - Devices industry, with a market cap of $600.6M.
TCMD Insider Trading Activity
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Nov 9, 2026 | BURKE WILLIAM W | director | Sell | 5,000 | $27.00 | $135.0K | 50,041 |
| Nov 5, 2026 | King Laura G. | director | Sell | 4,800 | $25.00 | $120.0K | 20,769 |
| Aug 12, 2026 | Dodd Sheri Louise | director, officer: Chief Executive Officer | Sell | 10,978 | $29.44 | $323.2K | 232,907 |
| May 13, 2026 | Birkemeyer Elaine M. | officer: CHIEF FINANCIAL OFFICER | Sell | 4,631 | $24.49 | $113.4K | 130,188 |
| Feb 26, 2026 | Birkemeyer Elaine M. | officer: CHIEF FINANCIAL OFFICER | Sell | 7,701 | $28.94 | $222.9K | 134,819 |
| Feb 26, 2026 | Burns Kristie | officer: Sr. VP Mktg & Clinical Affairs | Sell | 6,246 | $28.94 | $180.8K | 82,581 |
| Feb 26, 2026 | Dodd Sheri Louise | director, officer: Chief Executive Officer | Sell | 10,993 | $28.94 | $318.1K | 243,885 |
| Feb 24, 2026 | Birkemeyer Elaine M. | officer: CHIEF FINANCIAL OFFICER | Sell | 5,518 | $28.30 | $156.1K | 142,716 |
| Feb 24, 2026 | Burns Kristie | officer: Sr. VP Mktg & Clinical Affairs | Sell | 4,439 | $28.30 | $125.6K | 88,987 |
| Feb 24, 2026 | Dodd Sheri Louise | director, officer: Chief Executive Officer | Sell | 15,240 | $28.30 | $431.2K | 255,415 |
| Jan 2, 2026 | Burns Kristie | Sr. VP Mktg & Clinical Affairs | Sell | 5,139 | $28.85 | $148.3K | 0 |
| Aug 8, 2025 | Dodd Sheri Louise | Chief Executive Officer | Sell | 7,762 | $12.36 | $95.9K | 0 |
| May 12, 2025 | Birkemeyer Elaine M. | Chief Financial Officer | Sell | 2,921 | $9.94 | $29.0K | 0 |
| May 8, 2025 | Dodd Sheri Louise | Chief Executive Officer | Sell | 3,149 | $9.83 | $31.0K | 0 |
| May 7, 2025 | BURKE WILLIAM W | Director | Sell | 3,300 | $9.67 | $31.9K | 0 |
| Feb 25, 2025 | Birkemeyer Elaine M. | Chief Financial Officer | Sell | 2,066 | $14.51 | $30.0K | 0 |
| Feb 25, 2025 | Burns Kristie | Sr. VP Mktg & Clinical Affairs | Sell | 6,468 | $14.40 | $93.2K | 0 |
| Feb 25, 2025 | REUVERS DANIEL L. | Director | Sell | 28,338 | $14.18 | $401.9K | 0 |
| Feb 20, 2025 | Birkemeyer Elaine M. | Chief Financial Officer | Sell | 3,778 | $14.70 | $55.5K | 0 |
| Feb 20, 2025 | Burns Kristie | Sr. VP Mktg & Clinical Affairs | Sell | 4,830 | $14.65 | $70.8K | 0 |
| Feb 20, 2025 | REUVERS DANIEL L. | Director | Sell | 10,938 | $14.55 | $159.1K | 0 |
| Aug 14, 2024 | Ferstler Sherri Lee | Senior VP, Sales | Sell | 1,550 | $13.07 | $20.3K | 38,764 |
| May 20, 2024 | Birkemeyer Elaine M. | Chief Financial Officer | Sell | 3,041 | $13.68 | $41.6K | 61,295 |
| May 10, 2024 | BURKE WILLIAM W | Director | Sell | 2,500 | $14.06 | $35.1K | 25,273 |
| May 8, 2024 | Burns Kristie | Sr. VP Mktg & Clinical Affairs | Sell | 815 | $14.37 | $11.7K | 62,574 |
| Feb 29, 2024 | Burns Kristie | Sr. VP Mktg & Clinical Affairs | Sell | 1,334 | $15.52 | $20.7K | 63,632 |
| Feb 29, 2024 | REUVERS DANIEL L. | President and CEO | Sell | 6,085 | $15.52 | $94.4K | 239,423 |
| Feb 27, 2024 | Burns Kristie | Sr. VP Mktg & Clinical Affairs | Sell | 4,264 | $15.32 | $65.3K | 63,512 |
| Feb 27, 2024 | REUVERS DANIEL L. | President and CEO | Sell | 11,617 | $15.37 | $178.5K | 244,112 |
| Aug 9, 2023 | REUVERS DANIEL L. | President and CEO | Sell | 1,062 | $20.53 | $21.8K | 125,653 |
| May 16, 2023 | BURKE WILLIAM W | Director | Sell | 4,400 | $21.86 | $96.2K | 27,773 |
| May 10, 2023 | Burns Kristie | Sr. VP Mktg & Clinical Affairs | Sell | 786 | $18.65 | $14.7K | 36,562 |
| May 10, 2023 | PAULS ERIC | Senior VP, Sales | Sell | 550 | $18.55 | $10.2K | 29,498 |
| Mar 3, 2023 | Moen Brent | Chief Financial Officer | Sell | 1,391 | $14.10 | $19.6K | 48,760 |
| Feb 28, 2023 | Burns Kristie | Sr. VP Mktg & Clinical Affairs | Sell | 2,297 | $15.34 | $35.2K | 37,483 |
| Feb 28, 2023 | Moen Brent | Chief Financial Officer | Sell | 4,052 | $15.32 | $62.1K | 50,402 |
| Feb 28, 2023 | PAULS ERIC | Senior VP, Sales | Sell | 1,473 | $15.29 | $22.5K | 30,120 |
| Feb 28, 2023 | REUVERS DANIEL L. | President and CEO | Sell | 7,087 | $15.20 | $107.7K | 127,415 |
| Aug 10, 2022 | REUVERS DANIEL L. | President and CEO | Sell | 1,020 | $9.18 | $9.4K | 74,707 |
| Aug 8, 2022 | BURKE WILLIAM W | Director | Buy | 4,900 | $9.15 | $44.8K | 24,436+25% |
| May 23, 2022 | BURKE WILLIAM W | Director | Sell | 1,100 | $10.12 | $11.1K | 19,536 |
| May 10, 2022 | Burns Kristie | Sr. VP Mktg & Clinical Affairs | Sell | 999 | $13.04 | $13.0K | 21,959 |
| May 10, 2022 | PAULS ERIC | Senior VP, Sales | Sell | 600 | $13.03 | $7.8K | 18,299 |
| Mar 9, 2022 | Moen Brent | Chief Financial Officer | Sell | 176 | $20.64 | $3.6K | 51,899 |
| Mar 3, 2022 | Moen Brent | Chief Financial Officer | Sell | 1,632 | $20.33 | $33.2K | 52,075 |
| Feb 28, 2022 | Moen Brent | Chief Financial Officer | Sell | 624 | $19.85 | $12.4K | 53,707 |
| Feb 28, 2022 | REUVERS DANIEL L. | President and CEO | Sell | 877 | $19.78 | $17.4K | 75,727 |
| Aug 9, 2021 | REUVERS DANIEL L. | President and CEO | Sell | 1,063 | $43.11 | $45.8K | 22,667 |
| Jul 7, 2021 | REUVERS DANIEL L. | President and CEO | Sell | 2,961 | $49.75 | $147.3K | 23,730 |
| Jun 28, 2021 | BURKE WILLIAM W | Director | Sell | 6,761 | $55.00 | $371.9K | 8,533-44% |
Showing 1–50 of 53
1 / 2
TCMD Insider Buying Activity
The following table shows recent insider purchases of Tactile Systems Technology, Inc. (TCMD) stock reported via SEC Form 4 filings.
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Aug 8, 2022 | BURKE WILLIAM W | Director | Buy | 4,900 | $9.15 | $44.8K | 24,436+25% |
TCMD Insider Selling Activity
The following table shows recent insider sales of Tactile Systems Technology, Inc. (TCMD) stock reported via SEC Form 4 filings.
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Nov 9, 2026 | BURKE WILLIAM W | director | Sell | 5,000 | $27.00 | $135.0K | 50,041 |
| Nov 5, 2026 | King Laura G. | director | Sell | 4,800 | $25.00 | $120.0K | 20,769 |
| Aug 12, 2026 | Dodd Sheri Louise | director, officer: Chief Executive Officer | Sell | 10,978 | $29.44 | $323.2K | 232,907 |
| May 13, 2026 | Birkemeyer Elaine M. | officer: CHIEF FINANCIAL OFFICER | Sell | 4,631 | $24.49 | $113.4K | 130,188 |
| Feb 26, 2026 | Birkemeyer Elaine M. | officer: CHIEF FINANCIAL OFFICER | Sell | 7,701 | $28.94 | $222.9K | 134,819 |
| Feb 26, 2026 | Burns Kristie | officer: Sr. VP Mktg & Clinical Affairs | Sell | 6,246 | $28.94 | $180.8K | 82,581 |
| Feb 26, 2026 | Dodd Sheri Louise | director, officer: Chief Executive Officer | Sell | 10,993 | $28.94 | $318.1K | 243,885 |
| Feb 24, 2026 | Birkemeyer Elaine M. | officer: CHIEF FINANCIAL OFFICER | Sell | 5,518 | $28.30 | $156.1K | 142,716 |
| Feb 24, 2026 | Burns Kristie | officer: Sr. VP Mktg & Clinical Affairs | Sell | 4,439 | $28.30 | $125.6K | 88,987 |
| Feb 24, 2026 | Dodd Sheri Louise | director, officer: Chief Executive Officer | Sell | 15,240 | $28.30 | $431.2K | 255,415 |
| Jan 2, 2026 | Burns Kristie | Sr. VP Mktg & Clinical Affairs | Sell | 5,139 | $28.85 | $148.3K | 0 |
| Aug 8, 2025 | Dodd Sheri Louise | Chief Executive Officer | Sell | 7,762 | $12.36 | $95.9K | 0 |
| May 12, 2025 | Birkemeyer Elaine M. | Chief Financial Officer | Sell | 2,921 | $9.94 | $29.0K | 0 |
| May 8, 2025 | Dodd Sheri Louise | Chief Executive Officer | Sell | 3,149 | $9.83 | $31.0K | 0 |
| May 7, 2025 | BURKE WILLIAM W | Director | Sell | 3,300 | $9.67 | $31.9K | 0 |
| Feb 25, 2025 | Birkemeyer Elaine M. | Chief Financial Officer | Sell | 2,066 | $14.51 | $30.0K | 0 |
| Feb 25, 2025 | Burns Kristie | Sr. VP Mktg & Clinical Affairs | Sell | 6,468 | $14.40 | $93.2K | 0 |
| Feb 25, 2025 | REUVERS DANIEL L. | Director | Sell | 28,338 | $14.18 | $401.9K | 0 |
| Feb 20, 2025 | Birkemeyer Elaine M. | Chief Financial Officer | Sell | 3,778 | $14.70 | $55.5K | 0 |
| Feb 20, 2025 | Burns Kristie | Sr. VP Mktg & Clinical Affairs | Sell | 4,830 | $14.65 | $70.8K | 0 |
| Feb 20, 2025 | REUVERS DANIEL L. | Director | Sell | 10,938 | $14.55 | $159.1K | 0 |
| Aug 14, 2024 | Ferstler Sherri Lee | Senior VP, Sales | Sell | 1,550 | $13.07 | $20.3K | 38,764 |
| May 20, 2024 | Birkemeyer Elaine M. | Chief Financial Officer | Sell | 3,041 | $13.68 | $41.6K | 61,295 |
| May 10, 2024 | BURKE WILLIAM W | Director | Sell | 2,500 | $14.06 | $35.1K | 25,273 |
| May 8, 2024 | Burns Kristie | Sr. VP Mktg & Clinical Affairs | Sell | 815 | $14.37 | $11.7K | 62,574 |
| Feb 29, 2024 | Burns Kristie | Sr. VP Mktg & Clinical Affairs | Sell | 1,334 | $15.52 | $20.7K | 63,632 |
| Feb 29, 2024 | REUVERS DANIEL L. | President and CEO | Sell | 6,085 | $15.52 | $94.4K | 239,423 |
| Feb 27, 2024 | Burns Kristie | Sr. VP Mktg & Clinical Affairs | Sell | 4,264 | $15.32 | $65.3K | 63,512 |
| Feb 27, 2024 | REUVERS DANIEL L. | President and CEO | Sell | 11,617 | $15.37 | $178.5K | 244,112 |
| Aug 9, 2023 | REUVERS DANIEL L. | President and CEO | Sell | 1,062 | $20.53 | $21.8K | 125,653 |
| May 16, 2023 | BURKE WILLIAM W | Director | Sell | 4,400 | $21.86 | $96.2K | 27,773 |
| May 10, 2023 | Burns Kristie | Sr. VP Mktg & Clinical Affairs | Sell | 786 | $18.65 | $14.7K | 36,562 |
| May 10, 2023 | PAULS ERIC | Senior VP, Sales | Sell | 550 | $18.55 | $10.2K | 29,498 |
| Mar 3, 2023 | Moen Brent | Chief Financial Officer | Sell | 1,391 | $14.10 | $19.6K | 48,760 |
| Feb 28, 2023 | Burns Kristie | Sr. VP Mktg & Clinical Affairs | Sell | 2,297 | $15.34 | $35.2K | 37,483 |
| Feb 28, 2023 | Moen Brent | Chief Financial Officer | Sell | 4,052 | $15.32 | $62.1K | 50,402 |
| Feb 28, 2023 | PAULS ERIC | Senior VP, Sales | Sell | 1,473 | $15.29 | $22.5K | 30,120 |
| Feb 28, 2023 | REUVERS DANIEL L. | President and CEO | Sell | 7,087 | $15.20 | $107.7K | 127,415 |
| Aug 10, 2022 | REUVERS DANIEL L. | President and CEO | Sell | 1,020 | $9.18 | $9.4K | 74,707 |
| May 23, 2022 | BURKE WILLIAM W | Director | Sell | 1,100 | $10.12 | $11.1K | 19,536 |
| May 10, 2022 | Burns Kristie | Sr. VP Mktg & Clinical Affairs | Sell | 999 | $13.04 | $13.0K | 21,959 |
| May 10, 2022 | PAULS ERIC | Senior VP, Sales | Sell | 600 | $13.03 | $7.8K | 18,299 |
| Mar 9, 2022 | Moen Brent | Chief Financial Officer | Sell | 176 | $20.64 | $3.6K | 51,899 |
| Mar 3, 2022 | Moen Brent | Chief Financial Officer | Sell | 1,632 | $20.33 | $33.2K | 52,075 |
| Feb 28, 2022 | Moen Brent | Chief Financial Officer | Sell | 624 | $19.85 | $12.4K | 53,707 |
| Feb 28, 2022 | REUVERS DANIEL L. | President and CEO | Sell | 877 | $19.78 | $17.4K | 75,727 |
| Aug 9, 2021 | REUVERS DANIEL L. | President and CEO | Sell | 1,063 | $43.11 | $45.8K | 22,667 |
| Jul 7, 2021 | REUVERS DANIEL L. | President and CEO | Sell | 2,961 | $49.75 | $147.3K | 23,730 |
| Jun 28, 2021 | BURKE WILLIAM W | Director | Sell | 6,761 | $55.00 | $371.9K | 8,533-44% |
TCMD Insiders
Similar Stocks to TCMD
SYK
Stryker Corporation
$309.63+0.02%
$121.36B
BSX
Boston Scientific Corporation
$43.81-1.22%
$65.41B
EW
Edwards Lifesciences Corporation
$106.64-0.24%
$60.84B
DXCM
DexCom, Inc.
$81.87-1.72%
$31.08B
ZBH
Zimmer Biomet Holdings, Inc.
$101.81-1.31%
$19.53B
GKOS
Glaukos Corporation
$245.01-0.28%
$14.55B
PODD
Insulet Corp.
$145.82-4.29%
$10.58B
BIO
Bio-Rad Laboratories, Inc.
$359.68-1.82%
$9.85B